Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,830
Total Claims
$1.6M
Drug Cost
1,084
Beneficiaries
$1,447
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-40%
Opioid rate vs peers
1.4% vs 2.2% avg
+3%
Cost per patient vs peers
$1,447 vs $1,411 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.4%
Opioid Rate
241
Opioid Claims
$2,390
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,881 claims · $1.2M
Generic: 15,777 claims · $325K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 155 | $201K |
| Apixaban | 157 | $172K |
| Fluticasone/Umeclidin/Vilanter | 112 | $115K |
| Empagliflozin | 55 | $76K |
| Rivaroxaban | 63 | $64K |
| Semaglutide | 51 | $59K |
| Mirabegron | 58 | $57K |
| Insulin Glargine,hum.Rec.Anlog | 65 | $51K |
| Dapagliflozin Propanediol | 23 | $40K |
| Dulaglutide | 18 | $30K |
| Insulin Degludec | 28 | $27K |
| Linaclotide | 24 | $23K |
| Insulin Detemir | 25 | $22K |
| Sitagliptin Phos/Metformin Hcl | 20 | $21K |
| Liraglutide | 11 | $21K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
1.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About